Literature DB >> 28167668

Myeloid Cell-Specific Knockout of NFI-A Improves Sepsis Survival.

Melissa B McPeak1, Dima Youssef1, Danielle A Williams2, Christopher Pritchett2, Zhi Q Yao1, Charles E McCall3, Mohamed El Gazzar4.   

Abstract

Myeloid progenitor-derived suppressor cells (MDSCs) arise from myeloid progenitors and suppress both innate and adaptive immunity. MDSCs expand during the later phases of sepsis in mice, promote immunosuppression, and reduce survival. Here, we report that the myeloid differentiation-related transcription factor nuclear factor I-A (NFI-A) controls MDSC expansion during sepsis and impacts survival. Unlike MDSCs, myeloid cells with conditional deletion of the Nfia gene normally differentiated into effector cells during sepsis, cleared infecting bacteria, and did not express immunosuppressive mediators. In contrast, ectopic expression of NFI-A in myeloid progenitors from NFI-A myeloid cell-deficient mice impeded myeloid cell maturation and promoted immune repressor function. Importantly, surviving septic mice with conditionally deficient NFI-A myeloid cells were able to respond to challenge with bacterial endotoxin by mounting an acute inflammatory response. Together, these results support the concept of NFI-A as a master molecular transcriptome switch that controls myeloid cell differentiation and maturation and that malfunction of this switch during sepsis promotes MDSC expansion that adversely impacts sepsis outcome.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  MDSCs; NFI-A; inflammation; sepsis; sepsis immunosuppression

Mesh:

Substances:

Year:  2017        PMID: 28167668      PMCID: PMC5364314          DOI: 10.1128/IAI.00066-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

2.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.

Authors:  Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 3.  Myeloid derived suppressor cells in transplantation.

Authors:  Jason R Lees; Agnes M Azimzadeh; Jonathan S Bromberg
Journal:  Curr Opin Immunol       Date:  2011-07-28       Impact factor: 7.486

Review 4.  Anti-inflammatory mechanisms of sepsis.

Authors:  Nicholas J Shubin; Sean F Monaghan; Alfred Ayala
Journal:  Contrib Microbiol       Date:  2011-06-09

Review 5.  The new normal: immunomodulatory agents against sepsis immune suppression.

Authors:  Noelle A Hutchins; Jacqueline Unsinger; Richard S Hotchkiss; Alfred Ayala
Journal:  Trends Mol Med       Date:  2014-01-30       Impact factor: 11.951

6.  Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression.

Authors:  Giuseppe Zardo; Alberto Ciolfi; Laura Vian; Linda M Starnes; Monia Billi; Serena Racanicchi; Carmen Maresca; Francesco Fazi; Lorena Travaglini; Nelida Noguera; Marco Mancini; Mauro Nanni; Giuseppe Cimino; Francesco Lo-Coco; Francesco Grignani; Clara Nervi
Journal:  Blood       Date:  2012-02-10       Impact factor: 22.113

Review 7.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

Review 8.  Myeloid derived suppressor cells and their role in diseases.

Authors:  Y Y Kong; M Fuchsberger; S D Xiang; V Apostolopoulos; M Plebanski
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

View more
  12 in total

1.  HuR promotes miRNA-mediated upregulation of NFI-A protein expression in MDSCs during murine sepsis.

Authors:  Isatou Bah; Tuqa Alkhateeb; Ajinkya Kumbhare; Dima Youssef; Zhi Q Yao; Gregory A Hawkin; Charles E McCall; Mohamed El Gazzar
Journal:  Mol Immunol       Date:  2020-05-28       Impact factor: 4.407

Review 2.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

Review 3.  Neutrophil Diversity in Health and Disease.

Authors:  Carlos Silvestre-Roig; Zvi G Fridlender; Michael Glogauer; Patrizia Scapini
Journal:  Trends Immunol       Date:  2019-05-31       Impact factor: 16.687

4.  S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.

Authors:  Tuqa Alkhateeb; Ajinkya Kumbhare; Isatou Bah; Dima Youssef; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  Mol Immunol       Date:  2019-05-09       Impact factor: 4.407

5.  The miR-223/nuclear factor I-A axis regulates inflammation and cellular functions in intestinal tissues with necrotizing enterocolitis.

Authors:  Yu Zheng Wu; Kathy Yuen Yee Chan; Kam Tong Leung; Hugh Simon Lam; Yuk Him Tam; Kim Hung Lee; Karen Li; Pak Cheung Ng
Journal:  FEBS Open Bio       Date:  2021-06-01       Impact factor: 2.693

Review 6.  Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections.

Authors:  Anca Dorhoi; Nelita Du Plessis
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 7.  The Yin and Yang of Myeloid Derived Suppressor Cells.

Authors:  Snehil Budhwar; Priyanka Verma; Rachna Verma; Sangeeta Rai; Kiran Singh
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

8.  Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis.

Authors:  Jun Dai; Ajinkya Kumbhare; Danielle A Williams; Dima Youssef; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  Innate Immun       Date:  2017-11-27       Impact factor: 2.680

Review 9.  Myeloid-Derived Suppressor Cells in Sepsis.

Authors:  Irene T Schrijver; Charlotte Théroude; Thierry Roger
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

10.  MDSCs are induced after experimental blunt chest trauma and subsequently alter antigen-specific T cell responses.

Authors:  Yvonne Hüsecken; Sylvia Muche; Monika Kustermann; Malena Klingspor; Annette Palmer; Sonja Braumüller; Markus Huber-Lang; Klaus-Michael Debatin; Gudrun Strauss
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.